Back to search

Article

An affinity-matured DLL4 ligand for broad-spectrum activation and inhibition of Notch signaling

2022-03-07

Abstract excerpt

<h4>ABSTRACT</h4> The Notch pathway regulates cell fate decisions and is an emerging target for regenerative and cancer therapies. Recombinant Notch ligands are attractive candidates for modulating Notch signaling; however, their intrinsically low receptor-binding affinity restricts their utility in biomedical applications. To overcome this limitation, we evolved variants of the ligand Delta-like 4 (DLL4) with en...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6905d612-3c94-52e0-97b1-4f10be963052
DOI
10.1101/2022.03.07.483330
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An affinity-matured DLL4 ligand for broad-spectrum activation and inhibition of Notch signalingDOI 10.1101/2022.03.07.483330
Select a neighboring publication to make it the new centre.